A detailed history of Invenomic Capital Management LP transactions in Enovis Corp stock. As of the latest transaction made, Invenomic Capital Management LP holds 712,669 shares of ENOV stock, worth $21.4 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
712,669
Previous 580,964 22.67%
Holding current value
$21.4 Million
Previous $18.2 Million 18.68%
% of portfolio
1.09%
Previous 1.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$25.74 - $35.94 $3.39 Million - $4.73 Million
131,705 Added 22.67%
712,669 $21.6 Million
Q2 2025

Aug 14, 2025

BUY
$29.65 - $37.35 $3.89 Million - $4.9 Million
131,187 Added 29.17%
580,964 $18.2 Million
Q1 2025

May 15, 2025

BUY
$35.51 - $47.99 $10.6 Million - $14.4 Million
299,658 Added 199.61%
449,777 $17.2 Million
Q4 2024

Feb 14, 2025

BUY
$38.5 - $49.33 $5.78 Million - $7.41 Million
150,119 New
150,119 $6.59 Million

Others Institutions Holding ENOV

About Enovis CORP


  • Ticker ENOV
  • Exchange NYSE
  • Sector Industrials
  • Industry Specialty Industrial Machinery
  • Shares Outstandng 54,129,500
  • Market Cap $1.62B
  • Description
  • Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...
More about ENOV
Track This Portfolio

Track Invenomic Capital Management LP Portfolio

Follow Invenomic Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invenomic Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Invenomic Capital Management LP with notifications on news.